Pantherna Therapeutics raises €3.5M Seed round

3 July 2019· Hennigsdorf, Germany· health, biotech, materials, b2b, deep_hardware

The funds will be used to advance R&D activities and hire additional scientific staff for the development of novel mRNA therapeutics to treat Acute Respiratory Distress Syndrome (ARDS).

Investors

LeadHigh-Tech Gründerfonds

Also participating

European Investment FundState of BrandenburgDetlev Riesner

About Pantherna Therapeutics

Stage

Series A

Headquarters

Hennigsdorf, Germany

Founded

2017

Team Size

6–20

Sectors

healthbiotechmaterialsb2bdeep_hardware

https://pantherna-therapeutics.com/

Source: https://htgf.de/en/pantherna-therapeutics-seed-financing-round/